Differential gene expression analysis reveals activation of growth promoting signaling pathways by tenascin-C

Cancer Research

Volumn 64, Issue 20, 2004, Pages 7377-7385

  Ruiz, Christian ^a   Huang, Wentao ^b   Hegi, Monika E ^c   Lange, Katrin ^b   Hamou, Marie France ^c   Fluri, Erika ^b   Oakeley, Edward J ^a   Chiquet Ehrismann, Ruth ^a   Orend, Gertraud ^b  

^a FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; ENDOTHELIN; FIBRONECTIN; GROWTH PROMOTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN C FOS; TENASCIN; TROPOMYOSIN; WNT PROTEIN;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENETIC ANALYSIS; GLIOBLASTOMA; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; UNINDEXED SEQUENCE; UPREGULATION;

ACTINS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CYTOSKELETAL PROTEINS; DNA-BINDING PROTEINS; DOWN-REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 2; MAP KINASE SIGNALING SYSTEM; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TENASCIN; TRANSCRIPTION FACTORS; TROPOMYOSIN; WNT PROTEINS;

EID: 5644220191     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-1234     Document Type: Article

References (49)

1. Chiquet-Ehrismann R, Chiquet M. Tenascins: regulation and putative functions during pathological stress. J Pathol 2003;200:488-99.
2. Huang W, Chiquet-Ehrismann R, Moyano JV, Garcia-Pardo A, Orend G. Interference of tenascin-C with syndecan-4 binding to fibronectin blocks cell adhesion and stimulates tumor cell proliferation. Cancer Res 2001;61:8586-94.
3. Miralles F, Posern G, Zaromytidou AI, Treisman R. Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell 2003;113:329-42.
4. Schwartz MA, Ginsberg MH. Networks and crosstalk: integrin signalling spreads. Nat Cell Biol 2002;4:E65-8.
5. Pollard TD, Borisy GG. Cellular motility driven by assembly and disassembly of actin filaments. Cell 2003;112:453-65.
6. Wenk MB, Midwood KS, Schwarzbauer JE. Tenascin-C suppresses Rho activation. J Cell Biol 2000;150:913-20.
7. Orend G, Huang W, Olayioye MA, Hynes NE, Chiquet-Ehrismann R. Tenascin-C blocks cell-cycle progression of anchorage-dependent fibroblasts on fibronectin through inhibition of syndecan-4. Oncogene 2003;22:3917-26.
8. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 2003;31:e15.
9. Shields JM, Mehta H, Pruitt K, Der CJ. Opposing roles of the extracellular signalregulated kinase and p38 mitogen-activated protein kinase cascades in Ras-mediated down-regulation of tropomyosin. Mol Cell Biol 2002;22:2304-17.
10. Godard S, Getz G, Delorenzi M, et al. Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes. Cancer Res 2003;63:6613-25.
11. Wagner S, Hofstetter W, Chiquet M, et al. Early osteoarthritic changes of human femoral head cartilage subsequent to femoro-acetabular impingement. Osteoarthritis Cartilage 2003;11:508-18.
12. Martin D, Brown-Luedi M, Chiquet-Ehrismann R. Tenascin-C signaling through induction of 14-3-3 tau. J Cell Biol 2003;160:171-5.
13. Ambar I, Sokolovsky M. Endothelin receptors stimulate both phospholipase C and phospholipase D activities in different cell lines. Eur Pharmacol 1993;245:31-41.
14. Bagnato A, Catt KJ. Endothelins as autocrine regulators of tumor cell growth. TEM 1998;9:378-83.
15. Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 2003;1653:1-24.
16. Bafico A, Liu G, Yaniv A, Gazit A, Aaronson SA. Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. Nat Cell Biol 2001;3:683-6.
17. Mao B, Niehrs C. Kremen2 modulates Dickkopf2 activity during Wnt/LRP6 signaling. Gene (Amst.) 2003;302:179-83.
18. Staal FJ, van Noort M, Strous GJ, Clevers HC. Wnt signals are transmitted through N-terminally dephosphorylated beta-catenin. EMBO Rep 2002;3:63-8.
19. van Noort M, Meeldijk J, van der Zee R, Destree O, Clevers H. Wnt signaling controls the phosphorylation status of beta-catenin. J Biol Chem 2002;277:17901-5.
20. Derksen PW, Tjin E, Meijer HP, et al. Illegitimate WNT signaling promotes proliferation of multiple myeloma cells. Proc Natl Acad Sci USA 2004;101:6122-7.
21. Riese J, Yu X, Munnerlyn A, et al. LEF-1, a nuclear factor coordinating signaling inputs from wingless and decapentaplegic. Cell 1997;88:777-87.
22. Roose J, Huls G, van Beest M, Hsu SC, Grosschedl R, Bienz M. Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1. Science (Wash. DC) 1999;285:1923-6.
23. Rockman SP, Currie SA, Ciavarella M, et al. Id2 is a target of the beta-catenin/T-cell factor pathway in colon carcinoma. J Biol Chem 2001;276:45113-9.
24. Umbhauet M, Djiane A, Goisset C, et al. The C-terminal cytoplasmic Lys-thr-X-X-X-Trp motif in frizzled receptors mediates Wnt/beta-catenin signalling. EMBO J 2000;19:4944-54.
25. Austin TW, Solar GP, Ziegler FC, Liem L, Matthews W. A role for the Wnt gene family in hematopoiesis: expansion of multilineage progenitor cells. Blood 1997;89:3624-35.
26. Liu BY, Kim YC, Leatherberty V, Cowin P, Alexander CM. Mammary gland development requires syndecan-1 to create a beta-catenin/TCF-responsive mammary epithelial subpopulation. Oncogene 2003;22:9243-53.
27. Tremble P, Chiquet-Ehrismann R, Werb Z. The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts. Mol Biol Cell 1994;5:439-53.
28. Giancotti FG, Ruoslahti E. Integrin signaling. Science (Wash. DC) 1999;285: 1028-32.
29. Eferl R, Wagner EF. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 2003;3:859-68.
30. Geijsen N, Uings IJ, Pals C, et al. Cytokine-specific transcriptional regulation through an IL-5Ralpha interacting protein. Science (Wash. DC) 2001;293:1136-8.
31. Hsueh YP, Wang TF, Yang FC, Sheng M. Nuclear translocation and transcription regulation by the membrane-associated guanylate kinase CASK/LIN-2. Nature (Lond.) 2000;404:298-302.
32. Aplin AE. Cell adhesion molecule regulation of nucleocytoplasmic trafficking. FEBS Lett 2003;534:11-4.
33. Pawlak G, Helfman DM. Cytoskeletal changes in cell transformation and tumorigenesis. Curr Opin Genet Dev 2001;11:41-7.
34. DesMarais V, Ichetovkin I, Condeelis J, Hitchcock-DeGregori SE. Spatial regulation of actin dynamics: a tropomyosin-free, actin-rich compartment at the leading edge. J Cell Sci 2002;115:4649-60.
35. Houle F, Rousseau S, Morrice N, et al. Extracellular signal-regulated kinase mediates phosphorylation of tropomyosin-1 to promote cytoskeleton remodeling in response to oxidative stress: impact on membrane blebbing. Mol Biol Cell 2003;14:1418-32.
36. Singer JM, Shaw JM. Mdm20 protein functions with Nat3 protein to acetylate Tpml protein and regulate tropomyosin-actin interactions in budding yeast. Proc Natl Acad Sci USA 2003;100:7644-9.
37. Cooper H, Feuerstein N, Noda M, Bassin RH. Suppression of tropomyosin synthesis, a common biochemical feature of oncogenesis by structurally diverse retroviral oncogenes. Mol Cell Biol 1985;5:972-83.
38. Prasad GL, Masuelli L, Raj MH, Harindranath N. Suppression of src-induced transformed phenotype by expression of tropomyosin-1. Oncogene 1999;18:2027-31.
39. Wang FL, Wang Y, Wong WK, et al. Two differentially expressed genes in normal human prostate tissue and in carcinoma. Cancer Res 1996;56:3634-7.
40. Bhattacharya B, Prasad GL, Valverius EM, Salomon DS, Cooper HL. Tropomyosins of human mammary epithelial cells: consistent defects of expression in mammary carcinoma cell lines. Cancer Res 1990;50:2105-12.
41. Hughes JA, Cooke-Yarborough CM, Chadwick NC, et al. High-molecular-weight tropomyosins localize to the contractile rings of dividing CNS cells but are absent from malignant pediatric and adult CNS tumors. Glia 2003;42:25-35.
42. Raval GN, Bharadwaj S, Levine EA, et al. Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors. Oncogene 2003;22:6194-203.
43. Herold-Mende C, Mueller MM, Bonsanto MM, Schmitt HP, Kunze S, Steiner HH. Clinical impact and functional aspects of tenascin-C expression during glioma progression. Int J Cancer 2002;98:362-9.
44. Persad S, Dedhar S. The role of integrin-linked kinase (ILK) in cancer progression. Cancer Metastasis Rev 2003;22:375-84.
45. Sikder HA, Devlin MK, Dunlap S, Ryu B, Alani RM. Id proteins in cell growth and tumorigenesis. Cancer Cell 2003;3:525-30.
46. Zebedee Z, Hara E. Id proteins in cell cycle control and cellular senescence. Oncogene 2001;20:8317-25.
47. Vandeputte DA, Troost D, Leenstra S, et al. Expression and distribution of id helix-loop-helix proteins in human astrocytic tumors. Glia 2002;38:329-38.
48. 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell 1990;60: 849-59.
49. Woods A, Longley RL, Tumova S, Couchman JR. Syndecan-4 binding to the high affinity heparin-binding domain of fibronectin drives focal adhesion formation in fibroblasts. Arch Biochem Biophys 2000;374:66-72.